Clinical Trials
2 trialsNCT03233711 2026-05-13
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT00893295 2013-12-18
Increasing Colorectal Cancer Screening in African Americans
National Cancer Institute (NCI)
Phase 3 Unknown